ROR1: An Update From ASH 2017
What have researchers discovered about ROR1 and its role in targeted CLL therapies? Andrew Schorr hosts coverage from the 2017 American Society of Hematology (ASH) conference to learn about the latest...
Author: patientpower
Added: 12/29/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Conferences | Hematology | Learning | Universities & Medical Training